In a recent discussion about hormone replacement therapy (HRT), published in the Multiple Sclerosis Journal it was suggested that women with MS should not be prevented from taking hormone replacement therapy when it is indicated independent of their MS status.
Most patients with MS are women, about 30 % of whom are in the peri- or post-menopausal phase. They usually deal with symptoms that are common to both menopause and MS (such as hot flashes, fatigue, lack of sleep, mood swings, and cognitive issues), and may mistakenly associate these symptoms with MS. There are proven benefits of HRT in controlling menopausal symptoms, and it’s important to note that having MS is not a contraindication to HRT.
More research needs to be done to determine the effects of HRT on women with MS going through menopause. Healthcare professionals should recognize the overlap in symptoms between MS and menopause and consider the potential benefits of HRT on symptom control and quality of life for women with MS.
Here at Belong, we will continue to update you with new medical and research developments. If you are interested in participating in a clinical trial, our team will gladly assist you in finding trials that are suitable for your medical needs. You are invited to respond here or contact us in a new post in this group.
This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service or treatment.
